FDA Label for Homwis Eczema Relief
View Indications, Usage & Precautions
Homwis Eczema Relief Product Label
The following document was submitted to the FDA by the labeler of this product Shenzhen Ishan Technology Co., Ltd. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredients
Tea tree oil 3% ------------------------------- Anti-fungal
Inactive Ingredients
Water, Beeswax, Colloidal oatmeal, Cocos
nucifera (coconut) oil, Elaeis guineensis(palm)
oil, Calendula officinalis extract, Hydrogenated
jojoba oil, Chrysanthellum indicum extract,
Hydrogenated olive oil, Butyrospermum parkii
(shea butter), Ceramide np, Mel, Propolis
extract, Glycerin, Sorbitol, Sucrose, Lauric
acid, Myristic acid, Sodium stearate, Sodium
dodecyl sulfate, Propylene glycol.
Uses
Helps relieve dryness, itching, redness,
and discomfort caused by eczema-prone skin.
Warnings
For external use only
When Using This Product
avoid contact with the eyes
Stop Use
Stop use and ask a doctor if rash or irritation appears or if any
adverse reactions occur
Ask A Doctor
Stop use and ask
a doctor if rash or irritation appears or if any
adverse reactions occur
Keep Out Of Reach Of Children
If swallowed, call a poison control center or seek medical attention immediately.
Dosage And Administration
First, wet your skin. Then lather the soap in
your hands, and apply the lather to your face
or body in a circular motion. Leave on skin for
two minutes, then rinse completely and pat dry
gently.
Other Information
Store at room temperature.
Indications & Usage
First, wet your skin. Then lather the soap in your hands, and apply the lather to your face or body in a circular motion. Leave on skin fortwo minutes, then rinse completely and pat dry gently.
* Please review the disclaimer below.
